drugset / Trial / NCT00306943
Annual Study for Fluarix Registration
Non-randomizedParallel-groupOpen-labelPrevention
Summary
A pre-requisite to the yearly licensing process of the Influenza vaccine (FluarixTM/ Influsplit SSW®) is to demonstrate in clinical studies, the immunogenicity and reactogenicity of the vaccine composed of the new strains (2005/2006).
Timeline
- Start
- 2005-07
- Primary completion
- 2005-08
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influsplit SSW® | Vaccine | — | — |